Coronavirus: Low-Cost COVID-19 Test Kits May Save Much More Coronavirus Infections in Indian
Low-Cost COVID-19 Test Kits May Save Much More Coronavirus Infections in Indian
In early October of this year, India, which was at the epicenter of the epidemic, announced that it was developing a new coronavirus test strip based on gene editing technology. The research and development team claimed that it has an accuracy rate of 96% and a false positive rate of as low as 2%.
Recently, this new crown test strip has been approved by the Indian health department for production and use, and the Indian industrial giant Tata Group has been authorized for mass production. Consistent with the news just announced in early October, the test price of this test strip is relatively cheap, only 7 US dollars ($7 is not affordable for most in India), about one-fifth of the current nucleic acid test price. And using this test strip to test results can be obtained within a few minutes, because it is based on gene editing technology, the test strip can almost immediately identify the unique arrangement in the viral DNA sequence.
India’s launch of high-quality and low-cost COVID-19 test strips will bring a new turning point to global epidemic prevention?
- Test Kit for Coronavirus: SARS-CoV-2 Nucleic Acid Detection Kit (Rapid PCR Fluorescence Method)
- Symptoms (COVID-19)
- LCD Display non-contact infrared thermometer For Body C/F Selection Surface Temperature
- SARS-Cov-2(COVID-19) IgM/IgG Antibody Test Kit (Colloidal Gold)
- How does ZeroVirus protect us from virus?
In addition, according to the source, this test strip is not “complete” at present, and his test needs to be assisted by a machine, but the research and development team is working hard to develop a test strip version that can be used completely independently. According to expectations, it will be deployed in areas where India’s vast medical resources and testing technology are poor, so as to quickly complete the nationwide new coronavirus testing in high-risk areas. As of the 22nd Beijing time, India has a total of 7.7069 million confirmed new crown patients, ranking second in the world. If such a cheap and efficient testing tool is promoted, it can even alleviate the pressure of the epidemic in the entire Southeast Asian region.
As an ancient civilization born in the Ganges River Basin, Indians possess the ability to invent and create that they are proud of. Although in recent years, due to the “caste system” and the excessive pursuit of sophisticated electronic fields, it has been criticized by the international community, but it is undeniable that the Indians are capable of finding new ways. Just look at this new crown test paper. If it is proven to be effective in India, it will be a major turning point in the global fight against the epidemic. National testing will no longer be a time-consuming, labor-intensive and remote dream.
India’s launch of high-quality and low-cost COVID-19 test strips will bring a new turning point to global epidemic prevention?
At the beginning of the outbreak in India, the small mobile nucleic acid detection vehicle launched in Delhi became a unique symbol of India’s fight against new coronary pneumonia. Hand over to the equipment for testing. The small volume of the car body is easy to travel through the streets of India. India now has a good cure rate for new crowns and is inseparable from the efficient detection capabilities brought by this equipment.
Speaking of Indians’ alternative ways, one has to mention the “Dabawala” food delivery system with a century-old history on the streets of Mumbai. 200,000 identical lunch boxes can be delivered on time and accurately only by relying on different colored marks and simple writing on the box, with almost no errors. Although it may not seem as convenient as our present takeaway, it appeared in the 19th century before the advent of the modern Internet.
India’s launch of high-quality and low-cost COVID-19 test strips will bring a new turning point to global epidemic prevention?
Going back to the newly invented test paper itself, the above two examples are not digressions. They basically prove that India is not as unbearable as we outsiders think. As Tata Group begins mass production of this test strip, perhaps the decisive turning point for humans to fight against new coronary pneumonia is really about to come.